Dr. Nancy Lee, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Cancer
Studies Squamous Cell Carcinoma
13 reported clinical trials
30 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
Stage II
2Squamous Cell Carcinoma
Stage III
Stage IV
p16 negative
Affiliated Hospitals
Clinical Trials Nancy Lee, MD is currently running
RP-3500 + Radiation Therapy
for Cancer
The purpose of this study is to test the safety of the study drug, RP-3500 when given in combination with palliative external beam radiotherapy (EBRT) to people who have metastatic solid tumor cancer with a mutation of the ATM gene. The study researchers will do tests to find the highest dose of RP3500 that causes few or mild side effects.
Recruiting1 award Phase 1 & 2
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
More about Nancy Lee, MD
Clinical Trial Related1 year of experience running clinical trials · Led 13 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Nancy Lee, MD has experience with
- Cisplatin
- Intensity-Modulated Radiation Therapy
- Proton Therapy
- Carboplatin
- Hypofractionated Palliative Re-irradiation
- Conventionally Fractionated Full Dose Re-irradiation
Breakdown of trials Nancy Lee, MD has run
Cancer
Squamous Cell Carcinoma
Head and Neck Cancers
Oropharyngeal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nancy Lee, MD specialize in?
Nancy Lee, MD focuses on Cancer and Squamous Cell Carcinoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Nancy Lee, MD currently recruiting for clinical trials?
Yes, Nancy Lee, MD is currently recruiting for 6 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Nancy Lee, MD has studied deeply?
Yes, Nancy Lee, MD has studied treatments such as Cisplatin, Intensity-Modulated Radiation Therapy, Proton Therapy.
What is the best way to schedule an appointment with Nancy Lee, MD?
Apply for one of the trials that Nancy Lee, MD is conducting.
What is the office address of Nancy Lee, MD?
The office of Nancy Lee, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.